Dr. Haijiang Wang 王海江
Chief Physician, Associate Professor
Department of Gastrointestinal Surgery, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of benign and malignant tumors of the gastrointestinal tract, urinary system, retroperitoneum, and other rare abdominal tumors.
Dr. Wang is Chief Physician, Associate Professor, and Director of Gastrointestinal Surgery at Xinjiang Medical University. A master’s supervisor and academic backbone, Dr. Wang completed advanced laparoscopic training in Hong Kong in 2004. Since 2005, Dr. Wang has performed radical surgeries for colorectal, gastric, pancreatic, biliary, urinary, and retroperitoneal tumors, as well as laparoscopic procedures for renal cysts, adrenal glands, gallbladders, and colorectal tumors.
Professional roles
- Member, Colorectal Cancer Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Wang Haijiang). Papers usually list the name as Haijiang Wang or Wang H.
Selected publications
34 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Iran J Public Health, 2022 (senior author): Expression and Prognostic Value of RAD51 in Adenocarcinoma at the Gastroesophageal Junction. PubMed 36415794
- Cancer Chemother Pharmacol, 2021 (senior author): Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis. PubMed 33611625
- Medicine (Baltimore), 2019 (senior author): Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer: A meta-analysis. PubMed 31027072
- J BUON, 2018 (senior author): Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months. PubMed 29745093
- Oncol Lett, 2017 (senior author): Effect of inhibiting Beclin-1 expression on autophagy, proliferation and apoptosis in colorectal cancer. PubMed 28989537
- Oncotarget, 2017 (senior author): MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway. PubMed 28938537
- Zhonghua Wei Chang Wai Ke Za Zhi, 2016 (senior author): [Treatment and prognosis of 108 patients with high-risk gastrointestinal stromal tumor]. PubMed 27928804
- Springerplus, 2016 (senior author): Effect and clinical significance of fast-track surgery combined with laparoscopic radical gastrectomy on the plasma level of vascular endothelial growth factor in gastric antrum cancer. PubMed 26835230
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion